Graft

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register today!

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, C. J.
Right arrow Articles by Gaston, R. S.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Graft, Vol. 4, No. 7, 514-518 (2001)
© 2001 SAGE Publications

Literature Review-Clinical: Disparities in Access to Renal Transplantation for African Americans

Carlton J. Young

University of Alabama at Birmingham

Robert S. Gaston

University of Alabama at Birmingham

Background. Minority populations, especially African Americans (AA), are disproportionately affected by deficiencies in our health care system. Because all Americans with end stage renal disease (ESRD) are eligible for government-funded care, one might expect ethnic discrepancies among patients with chronic kidney failure to be minimal. However, AA have long been noted to be at a significant disadvantage when compared with other ethnic groups. Methods. To assess the impact of evolving trends in the management of ESRD on AA, the authors reviewed published reports that examined the relationship between ethnicity, incidence of chronic renal failure, and access to optimal therapy. Results. The incidence of ESRD in AA is 4 times greater than in Caucasians. African Americans remain substantially less likely than whites to be referred for, or undergo, renal transplantation, the preferred treatment for chronic renal failure. Comprehensive explanation of these ongoing observations remains elusive. Conclusions. Despite remarkable advances in ESRD management during the last decade, AA in the United States remain significantly disadvantaged. Further evaluation of underlying causes and the development of specific remedies are warranted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?